Published in Invest Ophthalmol Vis Sci on September 01, 2006
Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS One (2012) 1.40
Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des (2013) 1.22
Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol (2011) 1.14
The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells. BMC Cancer (2009) 1.11
Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol (2014) 1.09
The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression. Genome Res (2007) 1.03
Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction. Invest Ophthalmol Vis Sci (2008) 0.99
Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells. J Exp Clin Cancer Res (2009) 0.94
Resveratrol and the eye: activity and molecular mechanisms. Graefes Arch Clin Exp Ophthalmol (2014) 0.90
The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization. Molecules (2014) 0.89
Chebulagic acid from Terminalia chebula causes G1 arrest, inhibits NFκB and induces apoptosis in retinoblastoma cells. BMC Complement Altern Med (2014) 0.87
Stromal cell-derived factor-1 is essential for photoreceptor cell protection in retinal detachment. Am J Pathol (2010) 0.86
Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance. PLoS One (2012) 0.86
Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Melanoma Res (2011) 0.82
Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastoma. Cancer Nanotechnol (2010) 0.80
A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma. PLoS One (2013) 0.78
Resveratrol and Ophthalmic Diseases. Nutrients (2016) 0.78
Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration. Cell Death Dis (2016) 0.77
Biofabrication of a novel biomolecule-assisted reduced graphene oxide: an excellent biocompatible nanomaterial. Int J Nanomedicine (2016) 0.77
The Benefits of Calorie Restriction and Calorie Restriction Mimetics as Related to the Eye. Open Longev Sci (2009) 0.77
Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy. Int J Nanomedicine (2016) 0.76
Apoptosis-related protein expression in rabbits with blast brain injury following early hyperbaric oxygen therapy. Neural Regen Res (2012) 0.76
Comparison of three methods for mitochondria isolation from the human liver cell line (HepG2). Gastroenterol Hepatol Bed Bench (2016) 0.75
Hypoxia-inducible factor-1α antagonizes the hypoxia-mediated osteoblast cell viability reduction by inhibiting apoptosis. Exp Ther Med (2015) 0.75
Escherichia coli Hfq has distinct interaction surfaces for DsrA, rpoS and poly(A) RNAs. Nat Struct Mol Biol (2004) 2.79
Viscocanalostomy in rhesus monkeys. Arch Ophthalmol (2004) 2.04
Effectively implementing evidence-based medicine. Ophthalmology (2013) 1.95
Slitlamp, specular, and light microscopic findings of human donor corneas after laser-assisted in situ keratomileusis. Arch Ophthalmol (2004) 1.46
Not for your eyes: information concealed through publication bias. Am J Ophthalmol (2008) 1.39
Registration of clinical trials. Arch Ophthalmol (2005) 1.39
Histopathology of radial keratotomy. Arch Ophthalmol (2005) 1.39
How to ensure our readers' trust: the proper attribution of authors and contributors. Am J Ophthalmol (2008) 1.38
Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol (2007) 1.35
Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res (2004) 1.32
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology (2002) 1.29
Prostaglandin-induced hair growth. Surv Ophthalmol (2002) 1.28
Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol (2007) 1.28
Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol (2002) 1.24
Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res (2007) 1.21
Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci (2007) 1.15
Entropy-driven folding of an RNA helical junction: an isothermal titration calorimetric analysis of the hammerhead ribozyme. Biochemistry (2004) 1.14
Ocular tuberculosis. Arch Ophthalmol (2005) 1.12
Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci (2003) 1.03
Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction. Invest Ophthalmol Vis Sci (2008) 0.99
Resveratrol: challenges in translation to the clinic--a critical discussion. Clin Cancer Res (2010) 0.97
Advanced keratomalacia with descemetocele in an infant with cystic fibrosis. Arch Ophthalmol (2005) 0.92
Development of choroidal neovascularization in rats with advanced intense cyclic light-induced retinal degeneration. Arch Ophthalmol (2010) 0.91
Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice. Ophthalmology (2003) 0.90
Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model. Arch Ophthalmol (2002) 0.89
Drug-induced cicatrising granulomatous conjunctivitis. Br J Ophthalmol (2007) 0.89
The Open Access initiative in scientific and biomedical publishing: fourth in the series on editorship. Am J Ophthalmol (2005) 0.88
The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. Cancer Immunol Immunother (2011) 0.87
Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol (2002) 0.87
Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models. Arch Ophthalmol (2004) 0.86
Aspergillus infection of the orbital apex masquerading as Tolosa-Hunt syndrome. Arch Ophthalmol (2007) 0.85
Ca2+ binding to EF hands 1 and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in ocular melanoma. Biochemistry (2004) 0.85
Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice. Arch Ophthalmol (2005) 0.85
Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells. J Agric Food Chem (2011) 0.84
Effect of latanoprost on hair growth in the bald scalp of the stump-tailed macacque: a pilot study. Acta Derm Venereol (2002) 0.84
Shaken adult syndrome: report of 2 cases. JAMA Ophthalmol (2013) 0.82
Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model. Arch Ophthalmol (2004) 0.82
Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Melanoma Res (2011) 0.82
Eyelid fibrous hamartoma with conjunctival angioma in an infant. Arch Ophthalmol (2007) 0.81
Vitelliform retinopathy in metastatic cutaneous melanoma with choroidal involvement. Arch Ophthalmol (2011) 0.80
Sympathetic ophthalmia following evisceration: a rare case. Ophthal Plast Reconstr Surg (2005) 0.80
Surgical removal of an atypical macular epiretinal membrane in neurofibromatosis type 2: clinicopathologic correlation and visual outcome. Arch Ophthalmol (2012) 0.80
Ophthalmic education: where have we come from, and where are we going? Am J Ophthalmol (2003) 0.79
A clinicopathologic case study of two patients with pediatric orbital IgG4-related disease. Orbit (2013) 0.79
Cancer-related diseases of the eye: the role of calcium and calcium-binding proteins. Biochem Biophys Res Commun (2004) 0.79
The editorial process for medical journals: I. Introduction of a series and discussion of the responsibilities of editors, authors, and reviewers. Am J Ophthalmol (2003) 0.79
Microsatellite instability and alterations of mismatch repair protein expression in choroidal melanomas. Arch Ophthalmol (2005) 0.78
Suppression of thrombospondin-1 expression during uveal melanoma progression and its potential therapeutic utility. Arch Ophthalmol (2012) 0.78
Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study. Arch Ophthalmol (2008) 0.78
Transitional cell carcinoma of the lacrimal sac presenting with bloody tears. JAMA Ophthalmol (2013) 0.78
1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol (2007) 0.78
Pocket of fluid in the lamellar interface after penetrating keratoplasty and laser in situ keratomileusis. Arch Ophthalmol (2003) 0.78
Ocular trauma resulting in enucleation: A 12-year experience from a large regional institution. WMJ (2014) 0.78
A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma. PLoS One (2013) 0.78
Postoperative visual acuity in patients with fuchs dystrophy undergoing descemet membrane-stripping automated endothelial keratoplasty: correlation with the severity of histologic changes. Arch Ophthalmol (2012) 0.78
Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice. Trans Am Ophthalmol Soc (2002) 0.77
Lichen simplex chronicus of the conjunctiva. JAMA Ophthalmol (2013) 0.77
Long-term survival in a patient with uveal melanoma and liver metastasis. Arch Ophthalmol (2004) 0.76
Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy. Int Immunopharmacol (2011) 0.76
Uveal melanoma masquerading as pigment dispersion glaucoma. Arch Ophthalmol (2008) 0.75
Sebaceous cell carcinoma of the eyelid: a rapidly enlarging lesion with massive xanthogranulomatous inflammation. Ophthal Plast Reconstr Surg (2010) 0.75
Hydration with saline decreases toxicity of mice injected with calcitriol in preclinical studies. J Environ Pathol Toxicol Oncol (2013) 0.75
The occurrence and proposed significance of Schnabel cavernous degeneration in uveal melanoma. JAMA Ophthalmol (2014) 0.75
Melanoma, vitiligo, and uveitis. Ophthalmology (2010) 0.75
Bilateral Primary Mucinous Carcinoma of the Eyelid. Ophthal Plast Reconstr Surg (2016) 0.75
Evaluation of the antitumor effects of Herpes simplex virus lacking ribonucleotide reductase in a murine retinoblastoma model. Curr Eye Res (2004) 0.75
Amyloid deposits in temporal artery mimicking temporal arteritis in a patient with multiple myeloma. JAMA Ophthalmol (2013) 0.75
Racial melanosis: a striking presentation. JAMA Ophthalmol (2014) 0.75
Translational science with clinical promise. Arch Ophthalmol (2012) 0.75
Research: the track record justifies expanded support. Ophthalmology (2002) 0.75
Reaching the tipping point: from print to online publication. JAMA Ophthalmol (2013) 0.75
The JAMA Network Journals: New Names for the Archives Journals. Arch Otolaryngol Head Neck Surg (2012) 0.75
Iridocorneal endothelial syndrome. JAMA Ophthalmol (2014) 0.75
A presentation of invasive squamous cell carcinoma (white cornea). JAMA Ophthalmol (2014) 0.75
Meeting our ethical obligations in medical publishing: responsibilities of editors, authors, and readers of peer-reviewed journals. Arch Ophthalmol (2005) 0.75
Tradition and Innovation: The Archives of Ophthalmology and JAMA Ophthalmology. Arch Ophthalmol (2012) 0.75
Maintaining public trust in medical journals. Am J Ophthalmol (2005) 0.75
Examining and processing eye specimens. Methods Mol Biol (2014) 0.75
Anterior polar cataract: a clinical-pathologic correlation. JAMA Ophthalmol (2013) 0.75
Leiomyoma of the lower eyelid. JAMA Ophthalmol (2013) 0.75
Multiple pigmented basal cell carcinomas of the eyelids. JAMA Ophthalmol (2013) 0.75
The JAMA Network Journals: New Names for the Archives Journals. Arch Gen Psychiatry (2012) 0.75